Please try another search
The assets of the Fund are invested globally in the equities and equity-linked securities of companies operating in the pharmaceuticals, biotechnology, food technology and healthcare technology sectors and companies offering healthcare services.The objective of the Fund's investment activity is to earn as high a return on the invested assets as possible over the long term through active fund management. The aim is to outperform the benchmark index, which is the MSCI Daily (tr) World Net Health Care USD return index.
Name | Title | Since | Until |
---|---|---|---|
Hertta Alava | Portfolio Manager | 2007 | Now |
Biography | M.Soc.Sc. (Econ.), CEFA. Primary fund manager of the FIM Sahara Non-UCITS Fund and fund manager for the FIM Rohto Biomed. Alava has previously worked as an analyst and equity portfolio manager at Varma Mutual Pension Insurance Company. In the industry since 1998 and with the company since 2006. | ||
Tapani Koskenkari | Portfolio Manager | 2007 | Now |
Biography | M.Sc. (Econ.), Helsinki School of Economics and Ph.D. (Pharm.), University of Helsinki. Portfolio manager responsible for FIM Rohto BioMed since December 2007. More than ten years working experience in healthcare sector, mostly in pharmaceutical industry. Responsibilities have included working with healthcare companies worldwide and also different management positions in pharmaceutical industry. | ||
Tero Jaakkola | - | 2000 | 2007 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review